companydata.dkcompanydata.dk

Mmimetika ApS: Financial statements 2025

CVR: 43340743

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Mmimetika ApS (CVR 43340743) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 713,232 and a net result of DKK 256,210 compared with DKK 521,268 the year before. That is a decrease of 0.2% compared with the year before. Equity in the 2025 report amounted to DKK 6,245,880. The solvency ratio was 53.7%.

Gross Profit
DKK 713,232
Profit/Loss
DKK 256,210
Equity
DKK 6,245,880
Total Assets
DKK 11,620,389
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-713 t.256 t.6.2 mio.0
2024-714 t.521 t.6 mio.3
2023-42 t.-59 t.5.5 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Mmimetika ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Jan Mousing steps down as director of Mmimetika ApSDec 31, 2025

As of December 31, 2025, Jan Mousing has stepped down as director of Mmimetika ApS.

Mmimetika ApS appoints new auditorDec 16, 2025

As of December 16, 2025, REVISION OG RÅDGIVNINGSGRUPPEN GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of Mmimetika ApS.

Jakob Helding Rasmussen joins the board of Mmimetika ApSSep 3, 2025

As of September 3, 2025, Jakob Helding Rasmussen has joined the board of directors of Mmimetika ApS.

Mmimetika ApS: The 2024 annual report is outMay 26, 2025

Mmimetika ApS has published its annual report for 2024. Gross profit came to DKK 714,369, and the net result was DKK 521,268.

KetLace Biosciences ApS changes name to Mmimetika ApSMay 14, 2025

On May 14, 2025, the company changed its name from KetLace Biosciences ApS to Mmimetika ApS.

About Mmimetika ApS

Mmimetika ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named KetLace Biosciences ApS. The management consists of Karan Sarin. The board consists of Jakob Helding Rasmussen (chair), Allan Møller Rasmussen, Jens Christian Klibo and Mogens Johannsen. The company's owners include SEYDLITZ GRUPPEN ApS, Mousing Holding ApS and Thomas B. Poulsen Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 713,232 and a net result of DKK 256,210 compared with DKK 521,268 the year before. Equity in the 2025 report amounted to DKK 6,245,880.

Source: annual report 2025, Danish Business Authority

Other financial years